•Safety of Risankizumab during Pregnancy in IBD
•Gut Microbiome and Paediatric Inflammatory Bowel Disease: Emerging Mechanistic and Therapeutic Insights Into Pathogenesis and Microbiota-Based Approaches
•Clinical utility of pre-treatment 4-digit resolution HLA genotyping to guide anti-TNF choice and concomitant immunomodulator use
•Enteric opportunistic infections in patients with inflammatory bowel disease receiving biologic therapies: a retrospective cohort study
•Integrating perspectives on transabdominal intestinal ultrasound in inflammatory bowel disease management: a nationwide cross-sectional survey of physicians and patients in China
